We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




No Standard Treatment for Extreme Premature Babies

By HospiMedica International staff writers
Posted on 18 May 2015
Print article
A new study reveals that hospital practices vary widely in initiating active treatment in extremely preterm infants.

Researchers at the University of Iowa (Iowa City, USA), Wayne State University (Detroit, MI, USA), and other institutions conducted a study involving infants born between April 2006 and March 2011 at 24 hospitals. Excluding infants with congenital anomalies, 4,987 babies born before reaching 27 weeks of gestation were included in the analysis. Of these, 4,329 babies received active treatment, and outcomes were known for 4,704; active treatment was defined as any potentially lifesaving intervention administered after birth.

The results showed that the overall rates of active treatment ranged from 22.1% among infants born at 22 weeks of gestation to 99.8% among those born at 26 weeks of gestation. Active treatments included surfactant therapy, tracheal intubation, ventilatory support, parenteral nutrition, epinephrine, or chest compressions. Babies who did not receive active treatment tended to be small for their age, have one-minute Apgar scores of 3 or lower, and were less likely to have antenatal glucocorticoids or have been delivered by cesarean section.

The researchers also assessed survival and survival without severe neurological impairment once the babies reached 18–22 months of corrected age. Babies born at 26 weeks demonstrated an 81.4% survival rate, and a 75.6% rate of survival without severe impairment. For 22-week-old babies who were given active treatment, the rate of survival was 23.1%, the rate of survival without severe impairment was 15.4%, and the rate of survival without severe or moderate impairment was 9%. The study was published on May 7, 2015, in the New England Journal of Medicine (NEJM).

“Sometimes tiny babies with zero chance of surviving show signs of life at birth, and may be able to breathe for a short time if put in an incubator and hooked up to a breathing machine and intravenous treatments,” said study coauthor professor of pediatrics Edward Bell, MD. “But even so, if it's a baby that doesn't have a chance, we don't want to put the baby and the family through the discomfort. These are very difficult decisions and they need to be made on a case-by-case basis by the families and physicians.”

An estimated 15 million babies are born too early every year, and almost one million of them die each year due to complications of preterm birth. Many survivors face a lifetime of disability, including learning disabilities and visual and hearing problems. Globally, prematurity is the leading cause of death in children under the age of 5. And in almost all countries with reliable data, preterm birth rates are increasing. More than three-quarters of premature babies can be saved with feasible, cost-effective care, such as antenatal steroid injections to strengthen the babies’ lungs and antibiotics to treat newborn infections.

Related Links:

University of Iowa
Wayne State University


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Ultra Low Floor Level Bed
Solite Pro

Print article

Channels

Surgical Techniques

view channel
Image: Computational models can predict future structural integrity of a child’s heart valves (Photo courtesy of 123RF)

Computational Models Predict Heart Valve Leakage in Children

Hypoplastic left heart syndrome is a serious birth defect in which the left side of a baby’s heart is underdeveloped and ineffective at pumping blood, forcing the right side to handle the circulation to... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.